Skip to main content
. Author manuscript; available in PMC: 2014 Sep 18.
Published in final edited form as: J Gene Med. 2013 Jan;15(1):42–50. doi: 10.1002/jgm.2693

Fig. 2. Cellular proliferation of U-87 MG transfected with scramble, EGFR and β-catenin siRNA.

Fig. 2

(a) The proliferation of U-87 MG treated with control siRNA and siRNA targeting β-catenin alone or EGFR and β-catenin simultaneously during the 6-day observation period starting from the second day after transfection. (b) Bar graphs indicating cell viability using siRNA either individually or in combination compared with scramble siRNA on day 6. Data are expressed as percentage of viable cells relative to untreated control cultures. Asterisk indicates significant level in Student's t-test: *P < 0.05, **P < 0.01, n.s.: non-significant.